Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fuat Hulusi Demirelli"'
Autor:
Gülin Alkan Şen, Esra Aydın, Murad Guliyev, Nihan Şentürk Öztaş, Ezgi Değerli, Nebi Serkan Demirci, Zeynep Hande Turna, Fuat Hulusi Demirelli
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background The HER-2 status of breast cancer (BC) has been classified as negative or positive for a long time. Given the efficacy of novel anti-HER2-targeted antibody drug conjugates (ADCs) in HER2-low BC, a distinct subgroup of HER2-low tum
Externí odkaz:
https://doaj.org/article/98931270611d484a8f3f578cc960f2b5
Autor:
Emir ÇELİK, Muhammed Şamil ASLAN, Nilay ŞENGÜL SAMANCI, Mehmet KARADAĞ, Veysel SUZAN, Yasemin ÇAKAN ÇELİK, Nebi Serkan DEMİRCİ, Fuat Hulusi DEMİRELLİ
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 9, Iss 1, Pp 84-90 (2021)
Aim:Malnutrition is one of the most common clinical problems in cancer patients. Its frequency increases in hospitalized cancer patients. In this study, it was aimed to investigate the frequency of malnutrition and its effect on quality of life (QOL)
Externí odkaz:
https://doaj.org/article/b11ffa8bb28843cbbc507cf9d66e352f
Autor:
Nilay Sengul SAMANCİ, Emir CELİK, Ezgi DEGERLİ, Melih KASAP, Kerem ORUC, Sahin BEDİR, Sumeyra DERİN, Nihan SENTURK OZTAS, Burc Cagrı POYRAZ, Zeynep Hande TURNA, Fuat Hulusi DEMİRELLİ
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 8, Iss 2, Pp 138-144 (2020)
Aim:Sleep disorders are one of the most common problems in patients with malignancy and they severely decrease the quality of life. We sought to investigate the frequency of sleep disturbances, its quantity, quality and possible correlation with rela
Externí odkaz:
https://doaj.org/article/4ab956db61934316b6cc2b3a7bf179c0
Publikováno v:
Indian Journal of Dermatology, Vol 65, Iss 2, Pp 148-150 (2020)
Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related death worldwide. Cutaneous metastases of signet-ring cell gastric carcinoma are uncommon. Here, we report a metastatic gastric adenocarcino
Externí odkaz:
https://doaj.org/article/62ecf3807dd846d78667d2363a733de8
Autor:
Nilay Sengul Samanci, Muhammed Samil Aslan, Emir Celik, Nebi Serkan Demirci, Fuat Hulusi Demirelli, Mehmet Karadağ, Yasemin Cakan Celik, Veysel Suzan
Publikováno v:
Namık Kemal Tıp Dergisi. 9:84-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0430e1452a367e35a00f17bb34a74bab
https://doi.org/10.4274/nkmj.galenos.2021.02886
https://doi.org/10.4274/nkmj.galenos.2021.02886
Objective: Neoadjuvant chemotherapy (NAC) is a widely used treatment modality for breast cancer and may delay surgery for unresponsive patients. The objective of this study was to determine the predictive factors for complete pathological response an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07685e5fa43b05c1b54c68a60f5ee3fd
https://doi.org/10.37047/jos.2020-79256
https://doi.org/10.37047/jos.2020-79256
Autor:
Melih Kasap, Sahin Bedir, Kerem Oruc, Fuat Hulusi Demirelli, Nilay Sengul Samanci, Emir Celik, Ezgi Degerli, Sumeyra Derin, Burç Çağrı Poyraz, Nihan Senturk, Zeynep Turna
Publikováno v:
Namık Kemal Tıp Dergisi.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93935bbc80dd9f13b95461822d55bf82
https://doi.org/10.37696/nkmj.674879
https://doi.org/10.37696/nkmj.674879
Autor:
Mehmet Akif Ozturk, Suheyla Serdengecti, Deniz Tural, Mustafa Ozguroglu, Evin Buyukunal, Z. Savas Turna, F.S. Biricik, Fuat Hulusi Demirelli, Ozcan Yildiz, Nil Molinas Mandel
Publikováno v:
European Journal of Cancer. 47:S344
Results: Median age was 59 (33−79), visceral disease in 60% and multiple site in 34%; 8 (16%) pts developed brain metastasis during T. All had overexpression of HER2 by IHC, FISH was centrally assessed in 78% and not amplified in 8%. T was administ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::939db88e8273fec2757af5a75db00c05
https://doi.org/10.1016/s0959-8049(11)71488-5
https://doi.org/10.1016/s0959-8049(11)71488-5